pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

tmunity PRESS RELEASE ARCHIVE

Feb 22, 2023

Kite Completes Acquisition of Tmunity

Dec 20, 2022

Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer

Feb 9, 2021

Tmunity Therapeutics Announces Expansion of T Cell Engineered Therapy Collaboration

Jan 25, 2021

Tmunity Announces Appointment of Jeffrey Leiden M.D., Ph.D. as Chairman of the Board of Directors

Jan 5, 2021

Tmunity to Present at the 39th Annual J.P. Morgan Healthcare Conference

Dec 9, 2020

Tmunity to Present at the 2020 RBC Capital Markets Healthcare Private Company Conference

Nov 5, 2020

Tmunity to Present at Upcoming Investor Conferences

Sep 29, 2020

Tmunity to Present at Upcoming Investor Conferences

Sep 8, 2020

Tmunity Announces Additional Senior Leadership Appointments

Feb 19, 2020

Tmunity to Present at Upcoming Investor Conferences

Jan 15, 2020

Tmunity Announces First Patient Dosed in Phase 1 Clinical Trial with CART-TnMUC1

Jan 9, 2020

Tmunity to Present at the 38th Annual J.P. Morgan Healthcare Conference

Nov 4, 2019

Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients

Oct 31, 2019

Tmunity Raises $75 Million in Series B Financing to Advance Next-Generation T-Cell Therapies

Oct 1, 2019

Tmunity Announces Exclusive License and Research Collaboration with Children’s Hospital of Philadelphia to Advance GPC2 CAR-T Cell Therapy for Neuroblastoma

Sep 27, 2019

Tmunity Announces Presentation at the Cantor Fitzgerald 2019 Global Healthcare Conference

Aug 23, 2019

Tmunity Announces Participation at Upcoming Investor Conferences

Jul 9, 2019

Be The Match BioTherapies and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies

May 23, 2019

Tmunity Announces June 2019 Investor Conference Schedule

May 1, 2019

Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers

Mar 1, 2019

Tmunity Announces Participation at Four Upcoming Investor Conferences

Feb 14, 2019

Tmunity Appoints Patrick Gray and Garry Nicholson to its Board of Directors as Independent Directors

Dec 21, 2018

Tmunity to Present at the 37th Annual J.P. Morgan Healthcare Conference

Oct 2, 2018

FierceBiotech Names Tmunity as One of Its “Fierce 15” Biotech Companies of 2018

Sep 19, 2018

Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company

Sep 18, 2018

Tmunity Names Moji James as General Counsel and Executive Vice President

Sep 4, 2018

Tmunity Names Graeme Bell as Chief Financial Officer and Executive Vice President

Jul 10, 2018

Tmunity Appoints Christina Coughlin, MD, PhD, as Chief Medical Officer and Executive Vice President

Apr 19, 2018

Tmunity Raises Additional $35 Million in Series A Financing, Bringing Series A Total to $135 Million to Advance Next-Generation T Cell Therapies

Apr 3, 2018

Tmunity Appoints Jason Krentz as Chief Technology Officer and Head of Technical Operations

Jan 23, 2018

Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer

Jan 23, 2018

Be The Match BioTherapies Invests in Tmunity Therapeutics to Support Advancement of Next-Generation T cell Immunotherapies

May 9, 2017

Tmunity Therapeutics Names Michael Christiano Executive Vice President and Chief Business Officer

Dec 7, 2016

Tmunity Therapeutics Names Usman “Oz” Azam Chief Executive Officer

Jan 12, 2016

Tmunity Therapeutics, Inc. to Advance IND-Enabling Activities for Personalized Next-Generation Engineered T Cell Therapies with $10 Million Financing

Google Analytics Alternative